• Something wrong with this record ?

18 years of face transplantation: Adverse outcomes and challenges

B. Longo, B. Pomahac, M. Giacalone, M. Cardillo, V. Cervelli

. 2023 ; 87 (-) : 187-199. [pub] 20230915

Language English Country Netherlands

Document type Systematic Review, Journal Article, Review

BACKGROUND: Since the first procedure performed in 2005, face transplantation has been debated as viable approach for the treatment of severe craniofacial defects. Despite the benefits provided, the experience in face allotransplantation has brought to light a significant risk of complications, including allograft removal or loss, and mortality. The present study is intended to provide an updated review on complications and major challenges witnessed over 18 years of experience in the field. METHODS: A systematic review of PubMed, MEDLINE, Cochrane, Google, and Google Scholar databases on face transplantation was conducted according to PRISMA guidelines up to April 2023. Articles providing details on cases of face allograft loss, removal, and patient death were included. Online articles and media reports were assessed to include information not disclosed in peer-reviewed literature. Face transplant centers were contacted to have updated follow-up information on single-face transplant cases. RESULTS: The search yielded 1006 reports, of which 28 were included. On a total of 48 procedures performed in 46 patients, adverse outcomes were gleaned in 14 cases (29%), including seven allograft losses (14.6%), and the death of ten patients (21.7%). Chronic rejection was the leading cause of allograft loss, with a median time from transplant to irreversible rejection of 90 months (IQR 88.5-102). The main causes of death were infectious complications, followed by malignancies, non-compliance to immunosuppression, and suicide. The median time to death was 48.5 months (IQR 19-122). CONCLUSIONS: To the best of our knowledge, this is the first study providing a comprehensive review of adverse outcomes in face transplantation. Considering the high rate of major complications, the heterogeneity of cases and single-center approaches, and the absence of published standards of care, the development of a consensus by face transplant teams holds the key to the field's advancement.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24003181
003      
CZ-PrNML
005      
20240509113207.0
007      
ta
008      
240220e20230915ne f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.bjps.2023.09.043 $2 doi
035    __
$a (PubMed)37879143
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Longo, Benedetto $u Chair of Plastic and Reconstructive Surgery, Department of Surgical Sciences, Tor Vergata University of Rome, Rome, Italy. Electronic address: benedetto.longo@uniroma2.it
245    10
$a 18 years of face transplantation: Adverse outcomes and challenges / $c B. Longo, B. Pomahac, M. Giacalone, M. Cardillo, V. Cervelli
520    9_
$a BACKGROUND: Since the first procedure performed in 2005, face transplantation has been debated as viable approach for the treatment of severe craniofacial defects. Despite the benefits provided, the experience in face allotransplantation has brought to light a significant risk of complications, including allograft removal or loss, and mortality. The present study is intended to provide an updated review on complications and major challenges witnessed over 18 years of experience in the field. METHODS: A systematic review of PubMed, MEDLINE, Cochrane, Google, and Google Scholar databases on face transplantation was conducted according to PRISMA guidelines up to April 2023. Articles providing details on cases of face allograft loss, removal, and patient death were included. Online articles and media reports were assessed to include information not disclosed in peer-reviewed literature. Face transplant centers were contacted to have updated follow-up information on single-face transplant cases. RESULTS: The search yielded 1006 reports, of which 28 were included. On a total of 48 procedures performed in 46 patients, adverse outcomes were gleaned in 14 cases (29%), including seven allograft losses (14.6%), and the death of ten patients (21.7%). Chronic rejection was the leading cause of allograft loss, with a median time from transplant to irreversible rejection of 90 months (IQR 88.5-102). The main causes of death were infectious complications, followed by malignancies, non-compliance to immunosuppression, and suicide. The median time to death was 48.5 months (IQR 19-122). CONCLUSIONS: To the best of our knowledge, this is the first study providing a comprehensive review of adverse outcomes in face transplantation. Considering the high rate of major complications, the heterogeneity of cases and single-center approaches, and the absence of published standards of care, the development of a consensus by face transplant teams holds the key to the field's advancement.
650    _2
$a lidé $7 D006801
650    12
$a transplantace obličeje $x škodlivé účinky $x metody $7 D054445
650    _2
$a imunosupresivní léčba $x metody $7 D007165
650    _2
$a imunologická tolerance $7 D007108
650    _2
$a rejekce štěpu $7 D006084
655    _2
$a systematický přehled $7 D000078182
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Pomahac, Bohdan $u Division of Plastic and Reconstructive Surgery, Yale School of Medicine, New Haven, CT, USA
700    1_
$a Giacalone, Martina $u Chair of Plastic and Reconstructive Surgery, Department of Surgical Sciences, Tor Vergata University of Rome, Rome, Italy
700    1_
$a Cardillo, Massimo $u National Transplants Center, National Institute of Health, Italian Ministry of Health, Rome, Italy
700    1_
$a Cervelli, Valerio $u Chair of Plastic and Reconstructive Surgery, Department of Surgical Sciences, Tor Vergata University of Rome, Rome, Italy
773    0_
$w MED00008968 $t Journal of plastic, reconstructive & aesthetic surgery $x 1878-0539 $g Roč. 87 (20230915), s. 187-199
856    41
$u https://pubmed.ncbi.nlm.nih.gov/37879143 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240220 $b ABA008
991    __
$a 20240509113201 $b ABA008
999    __
$a ok $b bmc $g 2088837 $s 1212921
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 87 $c - $d 187-199 $e 20230915 $i 1878-0539 $m Journal of plastic, reconstructive & aesthetic surgery $n J Plast Reconstr Aesthet Surg $x MED00008968
LZP    __
$a Pubmed-20240220

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...